| Dr Leonard Yale Kerwin, MD | |
|
6330 Orchard Lake Rd Ste 120, West Bloomfield, MI 48322-2398 | |
| (248) 462-6045 | |
| Not Available |
| Full Name | Dr Leonard Yale Kerwin |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 14 Years |
| Location | 6330 Orchard Lake Rd Ste 120, West Bloomfield, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942525837 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 4301096099 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital - Farmington Hills | Farmington hills, MI | Hospital |
| Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwest Center For Dermatology And Pathology Pllc | 0446330492 | 43 |
News Archive
An innovative procedure may improve outcomes in people with a degenerative eye disease, suggest five-year results from a study presented at AAO 2016, the 120th annual meeting of the American Academy of Ophthalmology.
Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.
Despite cancer being a leading cause of death worldwide, treatment options for many types of cancers remain limited. This is partly due to the in vitro tools used to model cancers, which cannot adequately predict the behavior of a cancer or its sensitivity to drugs.
Early adult general cognitive ability (GCA) - the diverse set of skills involved in thinking, such as reasoning, memory and perception - is a stronger predictor of cognitive function and reserve later in life than other factors, such as higher education, occupational complexity or engaging in late-life intellectual activities, report researchers in a new study publishing January 21 in PNAS.
A Lancet World Report article examines the decision to restore USAID's policy department as part of broader reform efforts at the agency.
› Verified 6 days ago
| Entity Name | University Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447299797 PECOS PAC ID: 8628087681 Enrollment ID: O20060419000518 |
News Archive
An innovative procedure may improve outcomes in people with a degenerative eye disease, suggest five-year results from a study presented at AAO 2016, the 120th annual meeting of the American Academy of Ophthalmology.
Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.
Despite cancer being a leading cause of death worldwide, treatment options for many types of cancers remain limited. This is partly due to the in vitro tools used to model cancers, which cannot adequately predict the behavior of a cancer or its sensitivity to drugs.
Early adult general cognitive ability (GCA) - the diverse set of skills involved in thinking, such as reasoning, memory and perception - is a stronger predictor of cognitive function and reserve later in life than other factors, such as higher education, occupational complexity or engaging in late-life intellectual activities, report researchers in a new study publishing January 21 in PNAS.
A Lancet World Report article examines the decision to restore USAID's policy department as part of broader reform efforts at the agency.
› Verified 6 days ago
| Entity Name | Ronald D Kerwin Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992754485 PECOS PAC ID: 0749280303 Enrollment ID: O20070104000186 |
News Archive
An innovative procedure may improve outcomes in people with a degenerative eye disease, suggest five-year results from a study presented at AAO 2016, the 120th annual meeting of the American Academy of Ophthalmology.
Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.
Despite cancer being a leading cause of death worldwide, treatment options for many types of cancers remain limited. This is partly due to the in vitro tools used to model cancers, which cannot adequately predict the behavior of a cancer or its sensitivity to drugs.
Early adult general cognitive ability (GCA) - the diverse set of skills involved in thinking, such as reasoning, memory and perception - is a stronger predictor of cognitive function and reserve later in life than other factors, such as higher education, occupational complexity or engaging in late-life intellectual activities, report researchers in a new study publishing January 21 in PNAS.
A Lancet World Report article examines the decision to restore USAID's policy department as part of broader reform efforts at the agency.
› Verified 6 days ago
| Entity Name | Midwest Center For Dermatology & Pathology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003095084 PECOS PAC ID: 0446330492 Enrollment ID: O20080103000679 |
News Archive
An innovative procedure may improve outcomes in people with a degenerative eye disease, suggest five-year results from a study presented at AAO 2016, the 120th annual meeting of the American Academy of Ophthalmology.
Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.
Despite cancer being a leading cause of death worldwide, treatment options for many types of cancers remain limited. This is partly due to the in vitro tools used to model cancers, which cannot adequately predict the behavior of a cancer or its sensitivity to drugs.
Early adult general cognitive ability (GCA) - the diverse set of skills involved in thinking, such as reasoning, memory and perception - is a stronger predictor of cognitive function and reserve later in life than other factors, such as higher education, occupational complexity or engaging in late-life intellectual activities, report researchers in a new study publishing January 21 in PNAS.
A Lancet World Report article examines the decision to restore USAID's policy department as part of broader reform efforts at the agency.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Leonard Yale Kerwin, MD 6330 Orchard Lake Rd Ste 120, West Bloomfield, MI 48322-2398 Ph: (248) 462-6045 | Dr Leonard Yale Kerwin, MD 6330 Orchard Lake Rd Ste 120, West Bloomfield, MI 48322-2398 Ph: (248) 462-6045 |
News Archive
An innovative procedure may improve outcomes in people with a degenerative eye disease, suggest five-year results from a study presented at AAO 2016, the 120th annual meeting of the American Academy of Ophthalmology.
Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.
Despite cancer being a leading cause of death worldwide, treatment options for many types of cancers remain limited. This is partly due to the in vitro tools used to model cancers, which cannot adequately predict the behavior of a cancer or its sensitivity to drugs.
Early adult general cognitive ability (GCA) - the diverse set of skills involved in thinking, such as reasoning, memory and perception - is a stronger predictor of cognitive function and reserve later in life than other factors, such as higher education, occupational complexity or engaging in late-life intellectual activities, report researchers in a new study publishing January 21 in PNAS.
A Lancet World Report article examines the decision to restore USAID's policy department as part of broader reform efforts at the agency.
› Verified 6 days ago
Tarana Marie Mohammadi, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5839 W Maple Rd Ste 109, West Bloomfield, MI 48322 Phone: 248-855-7500 Fax: 248-855-5627 | |
Mrs. Suzanne Merkle, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6330 Orchard Lake Rd, #120, West Bloomfield, MI 48322 Phone: 248-855-3366 Fax: 248-855-6213 | |
Ronald David Kerwin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6330 Orchard Lake Rd, # 120, West Bloomfield, MI 48322 Phone: 248-855-3366 Fax: 248-855-6213 | |
Dr. Leonard M Cetner, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6330 Orchard Lake Rd, Suite 120, West Bloomfield, MI 48322 Phone: 248-855-3366 Fax: 248-855-6213 | |
Dr. Roxana L Chapman, DO Dermatology Medicare: Not Enrolled in Medicare Practice Location: 6900 Orchard Lake Rd, Ste 209, West Bloomfield, MI 48322 Phone: 248-855-7500 Fax: 248-855-5627 | |
Linda F. Stein Gold, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: Henry Ford Health System, 6777 West Maple Road, West Bloomfield, MI 48323 Phone: 248-661-6450 Fax: 248-661-6649 | |
Dr. Kay Elizabeth Watnick, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5839 W Maple Rd Ste 109, West Bloomfield, MI 48322 Phone: 248-855-7500 Fax: 248-855-5627 |